FindTrial
Sign In

Impact of hormone therapy on body, strength and quality of life in prostate cancer patients

Impact of anti-androgen therapy on body composition, strength and quality of life in prostate cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-8wnrg48
Enrollment
Unknown
Registered
2022-02-18
Start date
2021-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer patients

Interventions

This prospective cohort study will evaluate all patients for strength, body composition, and quality of life over time. As this is an observational study, there are no planned interventions. This stud
C04.588.945.440.770

Sponsors

Faculdade de Medicina de São José do Rio Preto - FAMERP
Lead Sponsor
Faculdade de Medicina de São José do Rio Preto - FAMERP
Collaborator

Eligibility

Sex/Gender
Male
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Prostate cancer patients over 65 years old; Metastatic disease in sensitive castration scenario; Patients in biochemical recurrence (ASTRO definition); Intermittent hormonal blockade, with last dose of anti-androgen >6 months ago

Exclusion criteria

Exclusion criteria: Radiotherapy or Chemotherapy in the last 30 days; Heart attack in the last 30 days; Neuromuscular disorders, hemiplegia or osteoarticular deformities of the upper/lower limbs

Design outcomes

Primary

MeasureTime frame
Differences in strength from 6 months to baseline measured by a hand-grip dynamometer—

Secondary

MeasureTime frame
Differences in body composition from 6 months to baseline assessed by measuring the proportion of lean muscle and fat at the L3 level using the sliceOmatic software. ;Differences in quality of slide from 6 months to baseline assessed through FACT-P and BFI questionnaires.—

Countries

Brazil

Contacts

Public ContactDaniel Araujo

Faculdade de Medicina de São José do Rio Preto - FAMERP

daniel.araujo@edu.famerp.br+551732015000 - ramal 5493

Outcome results

None listed

Source: REBEC (via WHO ICTRP)